| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Appropriate selection of participants for clinical trials in epilepsy
|
French, Jacqueline A
|
|
|
22 |
7 |
p. 554-555
|
artikel
|
| 2 |
Are CAR T cells the answer to myasthenia gravis therapy?
|
Meisel, Andreas
|
|
|
22 |
7 |
p. 545-546
|
artikel
|
| 3 |
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
|
Desborough, Michael J R
|
|
|
22 |
7 |
p. 557-567
|
artikel
|
| 4 |
Discontinuing disease-modifying multiple sclerosis therapies
|
Krysko, Kristen M
|
|
|
22 |
7 |
p. 543-545
|
artikel
|
| 5 |
Emmanuel Mignot, orexin, and the errors of Hypnos
|
Burton, Adrian
|
|
|
22 |
7 |
p. 552
|
artikel
|
| 6 |
End-of-life decision making in amyotrophic lateral sclerosis
|
Hardiman, Orla
|
|
|
22 |
7 |
p. 547-548
|
artikel
|
| 7 |
Frequency of euthanasia, factors associated with end-of-life practices, and quality of end-of-life care in patients with amyotrophic lateral sclerosis in the Netherlands: a population-based cohort study
|
van Eenennaam, Remko M
|
|
|
22 |
7 |
p. 591-601
|
artikel
|
| 8 |
Implications of a pathophysiological framework for cerebral amyloid angiopathy
|
Hernandez-Guillamon, Mar
|
|
|
22 |
7 |
p. 550-551
|
artikel
|
| 9 |
Kristen M Krysko
|
|
|
|
22 |
7 |
p. 553
|
artikel
|
| 10 |
Neuroimaging standards for research into small vessel disease—advances since 2013
|
Duering, Marco
|
|
|
22 |
7 |
p. 602-618
|
artikel
|
| 11 |
Palliative care to support the needs of adults with neurological disease
|
Kluger, Benzi M
|
|
|
22 |
7 |
p. 619-631
|
artikel
|
| 12 |
Prioritising integration of palliative care to prevent suffering
|
The Lancet Neurology,
|
|
|
22 |
7 |
p. 541
|
artikel
|
| 13 |
Progression of cerebral amyloid angiopathy: a pathophysiological framework
|
Koemans, Emma A
|
|
|
22 |
7 |
p. 632-642
|
artikel
|
| 14 |
Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
|
Corboy, John R
|
|
|
22 |
7 |
p. 568-577
|
artikel
|
| 15 |
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
|
Granit, Volkan
|
|
|
22 |
7 |
p. 578-590
|
artikel
|
| 16 |
Sigmund Freud's shift
|
Drouin, Emmanuel
|
|
|
22 |
7 |
p. 553
|
artikel
|
| 17 |
STRIVEing to describe small vessel disease
|
Frisoni, Giovanni B
|
|
|
22 |
7 |
p. 548-549
|
artikel
|
| 18 |
The artificial dichotomy of body and brain
|
Araújo, Rui
|
|
|
22 |
7 |
p. 556
|
artikel
|
| 19 |
Trials in intracerebral haemorrhage: a path to success?
|
Song, Lili
|
|
|
22 |
7 |
p. 542-543
|
artikel
|
Tijdschrift beschrijving